8-K: AMERISAFE Shareholders Approve Director Stock Plan Expansion and Elect Board Members at 2025 Annual Meeting
Annual Meeting Results
AMERISAFE, Inc. announced that its shareholders approved all proposals at the 2025 Annual Meeting, including an amendment to the Non-Employee Director Restricted Stock Plan to increase authorized shares and director compensation limits.
Summary
- AMERISAFE, Inc. held its 2025 Annual Meeting of shareholders on June 6, 2025, at its corporate headquarters in DeRidder, Louisiana.
- As of the record date of April 17, 2025, 19,050,315 shares of common stock were outstanding, with 18,023,934 shares represented in person or by proxy at the meeting.
- All matters submitted for shareholder approval, as described in the 2025 Proxy Statement filed on April 30, 2025, were approved.
- Shareholders elected Teri G. Fontenot, Billy B. Greer, and Jared A. Morris as directors for terms expiring at the 2028 annual meeting.
- The advisory vote to approve the compensation of the company's named executive officers was approved.
- The appointment of Ernst & Young LLP as the company's independent registered public accounting firm for 2025 was ratified.
- An amendment to the Non-Employee Director Restricted Stock Plan was approved, increasing the number of shares available for issuance by 50,000 and raising the maximum annual target value of restricted stock grants to each non-employee director to $200,000.
Sentiment
Score: 7
Explanation: The sentiment is generally positive as all management-backed proposals were approved, indicating stable corporate governance and shareholder support. The amendment to the director compensation plan is a positive for board retention. The only minor negative is the higher 'withheld' votes for one director, but it did not prevent his election.
Positives
- All proposals presented at the 2025 Annual Meeting received shareholder approval, indicating strong alignment between management and shareholders.
- The election of all nominated directors ensures continuity in the company's leadership.
- The approval of the amendment to the Non-Employee Director Restricted Stock Plan enhances the company's ability to attract and retain qualified non-employee directors through competitive compensation.
Negatives
- Jared A. Morris received a comparatively higher number of 'Votes Withheld' (2,078,938) for his re-election compared to the other two elected directors, Teri G. Fontenot (486,703) and Billy B. Greer (566,740), which could suggest some level of shareholder dissent or concern regarding his specific nomination.
Future Outlook
The document does not contain any specific forward-looking statements or financial guidance regarding the company's future performance or strategic direction.
Industry Context
This filing represents a routine corporate governance update following a company's annual shareholder meeting. The approval of director compensation plans and executive compensation is a common practice across publicly traded companies, reflecting ongoing efforts to align management and board incentives with shareholder interests. The specific increase in director compensation limits aligns with general market trends where companies adjust compensation to attract and retain top talent for their boards.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | NA | Teri G. Fontenot | June 6, 2025 | Re-elected for a term expiring at the 2028 annual meeting. |
| Director | NA | Billy B. Greer | June 6, 2025 | Re-elected for a term expiring at the 2028 annual meeting. |
| Director | NA | Jared A. Morris | June 6, 2025 | Re-elected for a term expiring at the 2028 annual meeting. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Plan Amendment | Amendment to the Non-Employee Director Restricted Stock Plan to increase the number of shares available for issuance by 50,000 shares and to increase the maximum annual target value of restricted stock that may be granted to each non-employee director to $200,000. | June 6, 2025 | Enhances the company's ability to attract and retain qualified non-employee directors by offering more competitive equity compensation, aligning director incentives with long-term shareholder value. |
Stakeholder Impact
- Shareholders: Approved all proposals, indicating continued support for the company's governance and compensation practices. The increase in director compensation could be viewed as a cost, but also as an investment in board quality.
- Non-Employee Directors: Will benefit from increased potential compensation through restricted stock grants, enhancing their alignment with shareholder interests and potentially improving board retention.
Next Steps
- The elected directors will serve terms expiring at the company's 2028 annual meeting of shareholders.
- The amended Non-Employee Director Restricted Stock Plan is now in effect, allowing for increased share issuance and higher annual target values for restricted stock grants to non-employee directors.
Key Dates
| Date | Description |
|---|---|
| April 17, 2025 | Record date for the 2025 Annual Meeting of shareholders. |
| April 30, 2025 | Date the company's proxy statement on Schedule 14A (2025 Proxy Statement) was filed with the U.S. Securities and Exchange Commission. |
| June 6, 2025 | Date of the 2025 Annual Meeting of shareholders. |
| June 9, 2025 | Date the Form 8-K Current Report was signed. |
Recommendation
holdKeywords
AMERISAFE, AMSF, SEC filing, 8-K, annual meeting, shareholder vote, corporate governance, director compensation, restricted stock plan, executive compensation, auditor ratification
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.